Citation 115847

FURUKAWA,M: SAKASHITA,H: KAMIDE,M: UMEDA,R:. (1990). INHIBITORY EFFECTS OF KAMPO MEDICINE ON EPSTEIN-BARR VIRUS ANTIGEN INDUCTION BY TUMOR PROMOTER.. 17(1)

Citation Details

TitleINHIBITORY EFFECTS OF KAMPO MEDICINE ON EPSTEIN-BARR VIRUS ANTIGEN INDUCTION BY TUMOR PROMOTER.
AuthorsFURUKAWA,M: SAKASHITA,H: KAMIDE,M: UMEDA,R:
Year1990
Volume17
Issue1

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (7)

Panax ginseng (ARALIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Ziziphus jujuba (RHAMNACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Pinellia ternata (ARACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Zingiber officinale (ZINGIBERACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Scutellaria baicalensis (LAMIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Glycyrrhiza glabra (FABACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE

Bupleurum falcatum (APIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
2
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
Show SPARQL Queries (1)